source
- Roche says its investigational breast cancer pill could outsell HerceptinRoche still has high sales hopes for its breast cancer pill giredestrant despite the drug’s failure in a first-line trial earlier this year. CEO Thomas Schinecker said Thursday that the drug could ...Endpoints · 4mo ago↗ source
- Sanofi defends Garijo appointment, says it is 'fully committed' to immunologySanofi’s first-quarter earnings call with the media on Thursday was an exercise in redirecting the narrative before its new CEO steps in next week. CFO François-Xavier Roger defended the company’s…Endpoints · 4mo ago↗ source
- OpenAI's head of health lays out the AI giant’s healthcare ambitionsOpenAI is launching ChatGPT for Clinicians, a free tool for doctors, nurse practitioners, physician assistants and pharmacists. It’s the latest product the AI giant has launched within healthcare,…